Clinical Trial Update: QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating QLC7401 for primary hypercholesterolemia or mixed hyperlipidemia with elevated LDL-C; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Hyperlipidemia

Drugs mentioned

• QLC7401

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Status: NOT_YET_RECRUITING